1-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-methylideneazetidine
Structure Info
- Chemspace ID
- CSSB00166114489 (In-Stock Building Blocks)
- IUPAC Name
- 1-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-methylideneazetidine
- Mol formula
- C18H24BNO3
- Mol weight
- 313 Da
- Catalog Number(s)
- BBLS00166114489, BBV-325543412, CSCR00166114489, EN300-55164095, bbls00166114489
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.67
- Heavy atoms count
- 23
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 39
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 1-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-methylideneazetidine (C18H24BNO3) - CSSB00166114489](/st/structure/200/3daa7e61e3f8826590832131532727e4/CC1%253DCC%253DC%2528C%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1CC%2528%253DC%2529C1.png "C18H24BNO3")
- Zoom the structure
- CSSB00166114489
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 1-[3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-methylideneazetidine - CSSB02522299374](/st/structure/200/660ca55b8b799b0abcc324de8f16b42d/CC1%253DCC%2528%253DCC%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1CC%2528%253DC%2529C1.png)
![Chemical structure of 1-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB02081609094](/st/structure/200/1428f5cc8c6ede1ee723d2f047e53d83/CC1%253DCC%253DC%2528C%2528%253DO%2529N2CCC2%2529C%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 1-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azepane - CSSB00348448696](/st/structure/200/a149174b29b6e752a142b76234c169d6/CC1%253DCC%253DC%2528C%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1CCCCCC1.png)
![Chemical structure of 3-(fluoromethyl)-1-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB02526912942](/st/structure/200/8def594a9a0bbce65f91398de49337cf/CC1%253DCC%253DC%2528C%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1CC%2528CF%2529C1.png)
![Chemical structure of 3,3-dimethyl-1-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB00248248871](/st/structure/200/edd560e753c35cedddf962e2a366883b/CC1%253DCC%253DC%2528C%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1CC%2528C%2529%2528C%2529C1.png)
![Chemical structure of 1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-methylideneazetidine - CSSB02522298490](/st/structure/200/7ad0c1ea077869a6875c3bb6037f1cf9/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CC%2528%253DC%2529C1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
